Anti-human CA9 monoclonal antibody, girentuximab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1012-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: WX-G250, cG250
target CA9
alias CAIX, MN
gene id Uniprot ID: Q16790
host species Chimeric
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human CA9, His tagged protein binds to Anti-CA9 Neutralizing antibody in a linear range of 0.128-80 ng/ml.

HEK293 cell line transfected with irrelevant protein (B) and human CA9 (A) were surface stained with Anti-CA9 mAb 1 ug/ml (girentuximab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.


PRODUCT

  • SKU

    DMS1012-100ug

  • Size

    100ug

  • Price

    $350

1